The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis

Vaccine

Volumn 28, Issue 31, 2010, Pages 5109-5113

  Farmaki, Evangelia ^a   Kanakoudi Tsakalidou, Florentia ^a   Spoulou, Vana ^b   Trachana, Maria ^a   Pratsidou Gertsi, Polyxeni ^a   Tritsoni, Maria ^b   Theodoridou, Maria ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

7 Valent conjugate pneumococcal vaccine; Anti TNF agents; Juvenile idiopathic arthritis

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; METHOTREXATE; PNEUMOCOCCUS VACCINE; PREDNISONE; TUMOR NECROSIS FACTOR ANTIBODY; ANTIRHEUMATIC AGENT; BACTERIUM ANTIBODY; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; TUMOR NECROSIS FACTOR ALPHA; VACCINE;

ANTIBODY TITER; ARTHRITIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; IMMUNOGENICITY; MALE; PAIN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SEROTYPE; SWELLING; ADOLESCENT; ANTAGONISTS AND INHIBITORS; ARTHRITIS, JUVENILE; BLOOD; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; HUMANS; MALE; METHOTREXATE; PNEUMOCOCCAL VACCINES; PREDNISONE; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, CONJUGATE; ARTHRITIS, JUVENILE;

EID: 77954760659     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.080     Document Type: Article

References (32)

1. Chira P., Sandborg C.I. Novel therapies in pediatric rheumatic diseases. Curr Opin Pediatr 2003, 15:579-585.
2. Atzeni F., Bendtzen K., Bobbio-Pallavicini F., Conti F., Cutolo M., Montecucco, et al. Infections and treatment of patients with rheumatic diseases. Clin Exp Rheumatol 2008, 26(1 Suppl. 48):S67-73.
3. Estrach C., Moots R.J., Andrews S., Williams D., Sykes H.R., Dawson J.K. High incidence of pneumonia in patients on anti-TNF therapy. Rheumatology 2002, 41(Suppl. 1):93.
4. Kroesen S., Widmer A.F., Tyndall A., Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF alpha therapy. Rheumatology 2003, 42:617-621.
5. Ellerin T., Rubin R.H., Weinblatt M.E. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003, 48:3013-3022.
6. Takashima K., Tateda K., Matsumoto T., Iizawa Y., Nakao M., Yamaguchi K. Role of tumour necrosis factor alpha in the pathogenesis of pneumococcal pneumonia in mice. Infect Immun 1997, 65:257-260.
7. Conti F., Rezai S., Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008, 8(2):124-128.
8. Wright S.A., Taggart A.J. Pneumococcal vaccination for RA patients on TNF-alpha antagonists. Rheumatology (Oxford) 2004, 43(4):523.
9. Elkayam O., Caspi D., Reitblatt T., Charboneau D., Rubins J.B. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004, 33(4):283-288.
10. Kapetanovic M.C., Saxne T., Sjöholm A., Truedsson L., Jönsson G., Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006, 45(1 (January)):106-111.
11. Visvanathan S., Keenan G.F., Baker D.G., Levinson A.I., Wagner C.L. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 2007, 34(5):952-957.
12. Kaine J.L., Kivitz A.J., Birbara C., Luo A.Y. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 2007, 34(2):272-279.
13. Gelinck L.B., van der Bijl A.E., Visser L.G., Huizinga T.W., van Hogezand R.A., Rijkers G.T., et al. Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23valent pneumococcal polysaccharide vaccine. Vaccine 2008, 26(27-28):3528-3533.
14. Advisory Committee on Immunization Practices Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49(RR-9):1-35.
15. Adamkiewicz T.V., Silk B.J., Howgate J., Baughman W., Strayhorn G., Sullivan K., et al. Effectiveness of the 7valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008, 121(3):562-569.
16. Spoulou V.I., Tsoumas D.L., Papaevangelou V.G., Mostrou G.I., Theodoridou M.C. Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children. Vaccine 2005, 23(46-47):5289-5293.
17. Nachman S., Kim S., King J., Abrams E.J., Margolis D., Petru A., et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics 2003, 112(1 (Pt. 1)):66-73.
18. Bliss S.J., O'Brien K.L., Janoff E.N., Cotton M.F., Musoke P., Coovadia H., et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 2008, 8(1):67-80.
19. Ling Lin P., Michaels M.G., Green M., Mazariegos G.V., Webber S.A., Lawrence K.S., et al. Safety and immunogenicity of the American Academy of Pediatrics-recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005, 116:160-167.
20. Kumar D., Rotstein C., Miyata G., Arlen D., Humar A. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 2003, 187(10):1639-1645.
21. Pao M., Papadopoulos E.B., Chou J., Glenn H., Castro-Malaspina H., Jakubowski A.A., et al. Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant 2008, 14(9):1022-1030.
22. Vieira S., Baldacci E.R., Carneiro-Sampaio M., Doria Filho U., Koch V.H. Evaluation of antibody response to the heptavalent pneumococcal conjugate vaccine in pediatric chronic kidney disease. Pediatr Nephrol 2009, 24(1):83-89.
23. Giannini E.H., Ruperto N., Ravelli A., Lovell D.J., Felson D.T., Martini A. Preliminary definition of improvement in juvenile idiopathic arthritis. Arthritis Rheum 1997, 40:1202-1209.
24. Siber G.R., Chang I., Baker S., Fernsten P., O'Brien K.L., Santosham M., et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 2007, 25:3816-3826.
25. Oosterhuis-Kafeja F., Beutels P., Van Damme P. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). Vaccine 2007, 25(12):2194-2212.
26. Ovsyannikova I.G., Jacobson R.M., Poland G.A. Variation in vaccine response in normal populations. Pharmacogenomics 2004, 5:417-427.
27. Koutouzis E., Daikos G., Roma E., Charissiadou A., Pangalis A., Liakopoulou T., et al. Streptococcus pneumoniae serotypes before and after introduction of pneumococcal conjugate vaccine in Greece (Abstract). 6th International Symposium on Pneumococci and Pneumococcal Diseases 2008.
28. Poulakou G., Katsarolis I., Matthaiopoulou I., Tsiodras S., Kanavaki S., Hatzaki D., et al. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology. Int J Antimicrob Agents 2007, 30(1):87-92.
29. Finn A., Booy R., Moxon R., Sharland M., Heath P. Should the new pneumococcal vaccine be used in high-risk children?. Arch Dis Child 2002, 87:18-21.
30. Casswall T.H., Fischler B. Vaccination of the immunocompromised child. Expert Rev Vaccines 2005, 4(5):725-738.
31. Glück T., Müller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008, 46(9):1459-1465.
32. Kanakoudi-Tsakalidou F., Trachana M., Pratsidou-Gertsi P., Tsitsami E., Kyriazopoulou-Dalaina V. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol 2001, 19(5 (September-October)):589-594.